We are live on ! Find out more
APTO

Aptose Biosciences, Inc.
APTO

Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

15 hedge funds and large institutions have $16.3M invested in Aptose Biosciences, Inc. in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

221% more capital inflows, than outflows

Capital inflows: $1.78M | Capital outflows: $556K

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

15% more funds holding

Funds holding: 13 → 15 (+2)

1.12% more ownership

Funds ownership: 15.5% → 16.62% (+1.1%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Sphera Funds Management
Sphera Funds Management
Israel
+$1.28M
2
DAFNA Capital Management
DAFNA Capital Management
California
+$277K
3
TMC
Trellus Management Company
Florida
+$126K
4
Spark Investment Management
Spark Investment Management
New York
+$70.6K
5
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$20.9K

Top Sellers

Rank Fund Capital Flow
1
BVF Inc
BVF Inc
California
-$356K
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$149K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$47.1K
4
Bank of America
Bank of America
North Carolina
-$4K

APTO Hedge Fund Activity: Q2 2015 in Review

15 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q2 2015, worth a combined $16.3M — up 3.5% from $15.8M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new APTO positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Sphera Funds Management, opening a new position worth an estimated $1.28M. The largest seller was BVF Inc, cutting an estimated $356K.

  • 15 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q2 2015, up from 13 in Q1 2015.
  • Funds reported $16.3M of Aptose Biosciences, Inc. stock for Q2 2015, up 3.5% quarter-over-quarter.
  • 3 funds opened new Aptose Biosciences, Inc. positions in Q2 2015 and 1 closed out, a net change of +2 holders.
  • The largest Aptose Biosciences, Inc. buyer in Q2 2015 was Sphera Funds Management, an estimated $1.28M added.
  • The largest Aptose Biosciences, Inc. seller in Q2 2015 was BVF Inc, an estimated $356K sold.

Based on aggregated 13F filings for Q2 2015.